Cerebrospinal Fluid (CSF) Proteomics

The Human Brain Proteome Project: Biological and Technological Challenges.- Guidelines for CSF Processing and Biobanking: Impact on the Identification and Development of Optimal CSF Protein Biomarkers.- Functional Analyses of Embryonic Cerebrospinal Fluid Proteins.-   CSF Sample Preparation for Data Independent Acquisition.- Sample Fractionation Techniques for CSF Peptide Spectral Library Generation.- Application of 2D-DIGE and iTRAQ Workflows to Analyse CSF in Gliomas.- Peptidomic Workflow Applied to Cerebrospinal Fluid Analysis.- Quantitative Evaluation of Different Protein Fractions of Cerebrospinal Fluid using 18O Labeling.- A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.- Determination of Cerebrospinal Fluid Proteome Variations by Isobaric-Labeling Coupled to Strong Cation Exchange Chromatography and Tandem Mass-Spectrometry.- SWATH Mass Spectrometry Applied to Cerebrospinal Fluid Differential Proteomics: Establishment of a Sample-Specific Method.- Top-Down Proteomics Applied to Human CSF.- Application of an Aptamer-Based Proteomics Assay (SOMAscanTM) in Rat CSF.- Monitoring the Cerebrospinal Fluid Cytokine Profile using Membrane-Based Antibody Arrays.- Selective and Sensitive Mass Spectrometric Identification of Immune Complexe Antigens in Cerebrospinal Fluid.- CSF N-glycoproteomics using MALDI MS Techniques in Neurodegenerative Diseases.- Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.- An Improved Assay for Quantitation of Cerebrospinal Fluid Cystatin C using Liquid Chromatography Tandem Mass Spectrometry.- Array-Based Profiling of Proteins and Autoantibody Repertoires in CSF.- Untargeted Metabolomics Relative Quantification by SWATH Mass Spectrometry Applied to Cerebrospinal